Literature DB >> 19213597

Effects of silencing Id-1 in cell culture of human adenoid cystic carcinoma.

Pei Liu1, Shaohua Liu, Hongshun Qi, Yutang Li, Haixian He, Fengcai Wei.   

Abstract

Adenoid cystic carcinoma (ACC) is a slow growing but highly invasive cancer with a high recurrence rate. Id (inhibitor of DNA binding) proteins are dominant regulators of basic helix-loop-helix transcription factors that control malignant cell behavior in many different tissues. This study aimed to identify the potential role of inhibiting DNA binding-1 (Id-1) in human salivary adenoid cystic carcinoma (SACC) progression. First, we compared the Id-1 protein expression in a human salivary adenoid cystic carcinoma cell line (ACCM) against three other cell lines and found that Id-1 protein expression in ACCM to be significantly higher. Then we measured Id-1 mRNA and protein expression in ACCM before and after RNA interference (RNAi), which showed successful inhibition of Id-1. Further studies then demonstrated that the proliferation and invasiveness of ACCM cells were dramatically down-regulated, and increased numbers of apoptotic cells were detected after Id-1 silencing. Consequently, our data suggest that Id-1 is a potential target in the treatment of human salivary adenoid cystic carcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19213597     DOI: 10.1016/j.oraloncology.2008.12.008

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  2 in total

1.  Inhibitor of DNA-binding-1/inhibitor of differentiation-1 (ID-1) is implicated in various aspects of gastric cancer cell biology.

Authors:  Wei Li; Chun-Hua Zhang; Yi-Lin Hong; Jun Li; Yong-Mei Hu; Cui-Fen Zhao
Journal:  Mol Biol Rep       Date:  2011-06-19       Impact factor: 2.316

Review 2.  The Id-protein family in developmental and cancer-associated pathways.

Authors:  Cornelia Roschger; Chiara Cabrele
Journal:  Cell Commun Signal       Date:  2017-01-25       Impact factor: 5.712

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.